JPMorgan Chase & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.6M | Sell |
|
|||||
|
2025
Q1 | $86M | Sell |
|
|||||
|
2024
Q4 | $102M | Sell |
|
|||||
|
2024
Q3 | $198M | Buy |
|
|||||
|
2024
Q2 | $213M | Buy |
|
|||||
|
2024
Q1 | $212M | Sell |
|
|||||
|
2023
Q4 | $236M | Sell |
|
|||||
|
2023
Q3 | $232M | Buy |
|
|||||
|
2023
Q2 | $226M | Buy |
|
|||||
|
2023
Q1 | $248M | Sell |
|
|||||
|
2022
Q4 | $265M | Buy |
|
|||||
|
2022
Q3 | $174M | Buy |
|
|||||
|
2022
Q2 | $134M | Buy |
|
|||||
|
2022
Q1 | $123M | Buy |
|
|||||
|
2021
Q4 | $114M | Sell |
|
|||||
|
2021
Q3 | $226M | Sell |
|
|||||
|
2021
Q2 | $313M | Buy |
|
|||||
|
2021
Q1 | $214M | Buy |
|
|||||
|
2020
Q4 | $218M | Sell |
|
|||||
|
2020
Q3 | $245M | Buy |
|
|||||
|
2020
Q2 | $344M | Buy |
|
|||||
|
2020
Q1 | $221M | Buy |
|
|||||
|
2019
Q4 | $156M | Buy |
|
|||||
|
2019
Q3 | $36.5M | Sell |
|
|||||
|
2019
Q2 | $62.8M | Sell |
|
|||||
|
2019
Q1 | $75.5M | Sell |
|
|||||
|
2018
Q4 | $98.8M | Sell |
|
|||||
|
2018
Q3 | $137M | Buy |
|
|||||
|
2018
Q2 | $114M | Buy |
|
|||||
|
2018
Q1 | $85.6M | Sell |
|
|||||
|
2017
Q4 | $141M | Buy |
|
|||||
|
2017
Q3 | $138M | Sell |
|
|||||
|
2017
Q2 | $151M | Sell |
|
|||||
|
2017
Q1 | $194M | Sell |
|
|||||
|
2016
Q4 | $268M | Sell |
|
|||||
|
2016
Q3 | $343M | Buy |
|
|||||
|
2016
Q2 | $263M | Sell |
|
|||||
|
2016
Q1 | $370M | Sell |
|
|||||
|
2015
Q4 | $590M | Buy |
|
|||||
|
2015
Q3 | $543M | Buy |
|
|||||
|
2015
Q2 | $372M | Buy |
|
|||||
|
2015
Q1 | $193M | Buy |
|
|||||
|
2014
Q4 | $50.1M | Buy |
|
|||||
|
2014
Q3 | $35.5M | Sell |
|
|||||
|
2014
Q2 | $53.4M | Sell |
|
|||||
|
2014
Q1 | $63M | Buy |
|
|||||
|
2013
Q4 | $23.3M | Sell |
|
|||||
|
2013
Q3 | $28.8M | Sell |
|
|||||
|
2013
Q2 | $45.5M | Buy |
|